Jim Luterman
EVP, Development at Eikonizo Therapeutics | Lexington, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Jim Luterman serves as Principal at JDL BioConsulting, where he leverages his extensive expertise in drug development to provide strategic guidance to small and emerging biotech companies. With a dynamic career spanning multiple functional areas within the biotechnology and pharmaceutical industries, Jim specializes in navigating the complexities of both preclinical and clinical stage products, particularly those targeting orphan diseases. His strategic vision and business acumen enable him to effectively translate scientific innovations into viable commercial opportunities, ensuring that groundbreaking therapies reach the patients who need them most.
At JDL BioConsulting, Jim is currently involved in several key projects that underscore his commitment to advancing biopharmaceutical development. He collaborates closely with clients to devise tailored development strategies, focusing on regulatory pathways, project management, and strategic alliances that align with FDA requirements. His deep understanding of the lifesciences landscape allows him to identify potential challenges and opportunities, guiding clients through the intricacies of commercialization.
Recognized as a flexible problem solver, Jim excels in fostering collaboration among cross-functional teams, ensuring that scientific, regulatory, and commercial perspectives are harmonized throughout the drug development process. His ability to build strategic partnerships enhances the potential for successful outcomes, making him a sought-after consultant in the biotech community. With a passion for innovation and a commitment to improving patient outcomes, Jim Luterman continues to make a significant impact in the field of biotechnology, helping to shape the future of drug development for rare diseases.
EVP, Development at Eikonizo Therapeutics in January 2024 to Present
Principal at JDL BioConsulting in October 2022 to January 2024
SVP, Head of Early-Stage Development and Partnering at Enzyvant in December 2020 to July 2022
SVP, rhAC Platform Head at Enzyvant in October 2019 to December 2020
Principal at JDL BioConsulting in February 2018 to October 2019
Executive Vice President, Research & Development at OvaScience in March 2016 to February 2018
Senior Vice President, Research & Development at OvaScience in January 2015 to March 2016
Vice President, Development at OvaScience in January 2014 to January 2015
Early Development Team Leader at Shire HGT in June 2012 to January 2014
Program Executive, Senior Director Strategic Planning and Program Management at Shire HGT in December 2008 to June 2012
Senior Director, Program Leader at CombinatoRx in August 2006 to December 2008
Director, Commercial Development at CombinatoRx in August 2005 to August 2006
Manager, New Product Commercialization at Biogen/Biogen Idec in June 2001 to August 2005
Senior Analyst at Decision Resources in January 2000 to June 2001
Research Assistant at Brigham and Women's Hospital in January 1990 to January 1993
See more
See less
Cross-functional Team Leadership
Biotechnology
Strategy
Clinical Development
Pharmaceutical Industry
Program Management
Drug Development
Lifesciences
Biopharmaceuticals
Business Development
FDA
Strategic Alliances
Management
Commercialization
Rare Diseases
Life Sciences
Leadership
Project Management
U.S. Food and Drug Administration (FDA)
See more
See less
Discover more about Eikonizo TherapeuticsWhat is Jim Luterman email address?
Email Jim Luterman at [email protected]. This email is the most updated Jim Luterman email found in 2026.
What is Jim Luterman phone number?
Jim Luterman phone number is +17817996384 and +17817182204.
How to contact Jim Luterman?
To contact Jim Luterman send an email to [email protected]. If you want to call Jim Luterman try calling on +17817996384 and +17817182204.
What is Jim Luterman net worth?
Jim Luterman has an estimated net worth of $750,000 to $999,999
What company does Jim Luterman work for?
Jim Luterman works for Eikonizo Therapeutics
What is Jim Luterman's role at Eikonizo Therapeutics?
Jim Luterman is EVP, Development
What industry does Jim Luterman work in?
Jim Luterman works in the Biotechnology Research industry.
Jim Luterman Email Addresses
Jim Luterman Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Jim Luterman
Owner at Varners Hilltop Septic Llc
Owner at Management Resources
Owner at Housemaster
Team Lead, Sam’s Club MAP Team at Sam's Club
Operations Manager | Group Manager, Program Management at Loyalty Research Center
Operations Executive at Orkin
Senior Sales Manager at Hilton Minneapolis
Technical Delivery Manager Health & Wellness at Walgreens
Information Technology Engineering Manager at Accenture Technology Solutions at Accenture
Co-Founder | Leadership Team at Twin Cities Tableau User Group
Executive Assistant To Chief Executive Officer at Billion Strong
Regional Manager-Philly Metro-Hologic Surgical at Hologic, Inc.
Account Manager at Rianlon Corporation
Business Strategist at Global Concepts
Vice President, Product Development & Management - Senior Manager at HSBC
Board Member; Membership Committee Co-chair at PRSA Detroit
IT Site Manager - Chevron Oronite at Chevron
Senior Producer at goop.com
Client Experience Manager at TKXS
Clinic Liaison at Oakland Unified School District
Head of Global Industry and Value at Appian Corporation
Director Of Procurement at Samsara
Show more
Show less